Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
Gland Surgery
|
September 16, 2024
A comparison of ondansetron in preventing postoperative nausea and vomiting for patients with or without preoperative anxiety with painless egg retrieval: a prospective, randomized, controlled trial
Ying Mou, Wei Zhao, Weizhou Pan, et al.
Translational Vision Science & Technology
|
January 14, 2026
Prognostic Modeling for the Failure of Intravenous Methylprednisolone and the Risk of Visual Disability in AQP4-IgG Positive NMOSD-ON
Yao Qiu, Yurong Zhang, Xiaoning Liu, et al.
Journal of Medicinal Chemistry
|
January 23, 2026
Discovery of SY-589, a Highly Potent and Orally Bioavailable Polθ Helicase Inhibitor for the Treatment of HR-Deficient Tumors
Chongxun Ge, Dazhi Feng, Song Shi, et al.
Journal of Medicinal Chemistry
|
July 25, 2024
Identification of 6-Fluorine-Substituted Coumarin Analogues as POLRMT Inhibitors with High Potency and Safety for Treatment of Pancreatic Cancer
Shengnan Zhou, Xiaotong Ze, Dazhi Feng, et al.
European Journal of Medicinal Chemistry
|
March 27, 2022
Novel inhibitors of AChE and Aβ aggregation with neuroprotective properties as lead compounds for the treatment of Alzheimer's disease
Yulin Liu, Giuseppe Uras, Itse Onuwaje, et al.
Veterinary Microbiology
|
June 17, 2017
Surveillance of antimicrobial resistance among Escherichia coli from chicken and swine, China, 2008-2015
Peng Zhang, Zhangqi Shen, Chunping Zhang, et al.
Chemical Science
|
August 6, 2025
Selectively triggered: ROS-activated Michael acceptor prodrug strategy to enhance tumor targeting efficacy
Dazhi Feng, Xinnan Li, Junkai Liu, et al.
Journal of Medicinal Chemistry
|
July 29, 2025
Design, Optimization, and Biological Evaluation of a Novel Quinoline-Based POLRMT Inhibitor for Prostate Cancer Therapy
Xinnan Li, Lihua Liu, Dazhi Feng, et al.
Journal of Medicinal Chemistry
|
March 30, 2023
Discovery of a Novel, Potent, Orally Active, and Safe Inhibitor Targeting Human Mitochondrial RNA Polymerase
Xinnan Li, Xiaotong Ze, Shengnan Zhou, et al.
ACS Chemical Neuroscience
|
November 16, 2022
Design, Synthesis, and Biological Evaluation of Novel Chromanone Derivatives as Multifunctional Agents for the Treatment of Alzheimer's Disease
Xinnan Li, Tiantian Li, Feiyan Zhan, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
Gland Surgery
|
September 16, 2024
A comparison of ondansetron in preventing postoperative nausea and vomiting for patients with or without preoperative anxiety with painless egg retrieval: a prospective, randomized, controlled trial
Ying Mou, Wei Zhao, Weizhou Pan, et al.
Translational Vision Science & Technology
|
January 14, 2026
Prognostic Modeling for the Failure of Intravenous Methylprednisolone and the Risk of Visual Disability in AQP4-IgG Positive NMOSD-ON
Yao Qiu, Yurong Zhang, Xiaoning Liu, et al.
Journal of Medicinal Chemistry
|
January 23, 2026
Discovery of SY-589, a Highly Potent and Orally Bioavailable Polθ Helicase Inhibitor for the Treatment of HR-Deficient Tumors
Chongxun Ge, Dazhi Feng, Song Shi, et al.
Journal of Medicinal Chemistry
|
July 25, 2024
Identification of 6-Fluorine-Substituted Coumarin Analogues as POLRMT Inhibitors with High Potency and Safety for Treatment of Pancreatic Cancer
Shengnan Zhou, Xiaotong Ze, Dazhi Feng, et al.
European Journal of Medicinal Chemistry
|
March 27, 2022
Novel inhibitors of AChE and Aβ aggregation with neuroprotective properties as lead compounds for the treatment of Alzheimer's disease
Yulin Liu, Giuseppe Uras, Itse Onuwaje, et al.
Veterinary Microbiology
|
June 17, 2017
Surveillance of antimicrobial resistance among Escherichia coli from chicken and swine, China, 2008-2015
Peng Zhang, Zhangqi Shen, Chunping Zhang, et al.
Chemical Science
|
August 6, 2025
Selectively triggered: ROS-activated Michael acceptor prodrug strategy to enhance tumor targeting efficacy
Dazhi Feng, Xinnan Li, Junkai Liu, et al.
Journal of Medicinal Chemistry
|
July 29, 2025
Design, Optimization, and Biological Evaluation of a Novel Quinoline-Based POLRMT Inhibitor for Prostate Cancer Therapy
Xinnan Li, Lihua Liu, Dazhi Feng, et al.
Journal of Medicinal Chemistry
|
March 30, 2023
Discovery of a Novel, Potent, Orally Active, and Safe Inhibitor Targeting Human Mitochondrial RNA Polymerase
Xinnan Li, Xiaotong Ze, Shengnan Zhou, et al.
ACS Chemical Neuroscience
|
November 16, 2022
Design, Synthesis, and Biological Evaluation of Novel Chromanone Derivatives as Multifunctional Agents for the Treatment of Alzheimer's Disease
Xinnan Li, Tiantian Li, Feiyan Zhan, et al.
Page
of 8